ArticleOncology reports2017

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.

Kiyoko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.